Correlation Between Eliem Therapeutics and Annovis Bio
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Annovis Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Annovis Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Annovis Bio, you can compare the effects of market volatilities on Eliem Therapeutics and Annovis Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Annovis Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Annovis Bio.
Diversification Opportunities for Eliem Therapeutics and Annovis Bio
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Eliem and Annovis is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Annovis Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annovis Bio and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Annovis Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annovis Bio has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Annovis Bio go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Annovis Bio
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.43 times more return on investment than Annovis Bio. However, Eliem Therapeutics is 1.43 times more volatile than Annovis Bio. It trades about -0.26 of its potential returns per unit of risk. Annovis Bio is currently generating about -0.5 per unit of risk. If you would invest 411.00 in Eliem Therapeutics on August 29, 2024 and sell it today you would lose (107.00) from holding Eliem Therapeutics or give up 26.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eliem Therapeutics vs. Annovis Bio
Performance |
| Timeline |
| Eliem Therapeutics |
| Annovis Bio |
Eliem Therapeutics and Annovis Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Annovis Bio
The main advantage of trading using opposite Eliem Therapeutics and Annovis Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Annovis Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will offset losses from the drop in Annovis Bio's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Annovis Bio vs. Bright Minds Biosciences | Annovis Bio vs. HP Inc | Annovis Bio vs. Intel | Annovis Bio vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |